Clinical trial
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile…
NCT00195377 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00195377 |
|---|---|
| Title | Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain |
| Official title | Evaluating Safety and QoL in Patients Treated With Etanercept: an Open Multicenter Study |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Arthritis, Psoriatic, Rheumatoid |
| Intervention type | Drug |
| Interventions | Etanercept |
| Enrollment | 1,000 |
| Start date | Apr 1, 2003 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Sep 19, 2005 |
| Last update posted | Jun 18, 2009 |
| Countries | Spain |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: